Streetbeat News

Price Targets

CRNX

JMP Securities analyst Jonathan Wolleben reiterates a Market Outperform rating on Crinetics Pharmaceuticals (CRNX) and maintains an $80 price target.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 4:45 pm

HY

Northland Capital Markets analyst Ted Jackson downgrades Hyster-Yale Materials (HY) from Outperform to Market Perform, while raising the price target from $80 to $90.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 4:44 pm

ARGX

JMP Securities analyst Jason Butler has maintained a Market Outperform rating on argenx (NASDAQ:ARGX) but lowered the price target from $471 to $468.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 4:43 pm

RBLX

MoffettNathanson analyst Clay Griffin upgrades Roblox (RBLX) from Sell to Neutral but lowers the price target from $31 to $26.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 4:42 pm

AMN

JMP Securities analyst Constantine Davides has reiterated a 'Market Outperform' rating on AMN Healthcare Services (NYSE:AMN), maintaining a price target of $75.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 4:41 pm

ONTO

Evercore ISI Group analyst Mark Lipacis maintains an Outperform rating on Onto Innovation (NYSE:ONTO) and raises the price target from $235 to $250.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 4:39 pm

SEDG

Deutsche Bank analyst Corinne Blanchard has maintained a Hold rating on SolarEdge Technologies (SEDG) and lowered the price target from $75 to $55.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 4:37 pm

SQSP

Mizuho analyst Siti Panigrahi upgraded Squarespace (NYSE:SQSP) to Buy from Neutral, with a price target increase to $50 from $34, citing potential for significant growth driven by Google Domains acquisition, pricing tailwinds, and Squarespace Payments. The company is expected to see 20%+ growth with 30% uFCF margins over the medium term. The Google Domains acquisition has already contributed $13 million in revenue, with expectations of substantial revenue contributions from domains and pricing increases in the coming years.

Portfolio Pulse from Nabaparna Bhattacharya

May 10, 2024 | 4:35 pm

SPB

Deutsche Bank analyst Steve Powers has maintained a Hold rating on Spectrum Brands Holdings (NYSE:SPB) and increased the price target from $85 to $91.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 4:34 pm

ALT

JMP Securities analyst Jonathan Wolleben maintains a Market Outperform rating on Altimmune (NASDAQ:ALT) but lowers the price target from $25 to $24.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 4:34 pm